These 2 small-cap ASX shares have soared, but a fund manager still tips them as buys

Here are two picks in the WAM Microcap portfolio.

| More on:
Small girl giving a fist bump with a piggy bank in front of her.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Despite the volatility, some small ASX shares have been climbing, yet one fund manager still thinks they’re opportunities
  • iCollege has risen significantly since August, but the fund manager thinks the market is underestimating how much earnings can grow with the borders now open
  • CogState has jumped since late September, and WAM thinks it can keep doing well if a drug gets approval

Fund manager Wilson Asset Management (WAM) has identified two top small-cap ASX shares in one of the portfolios it manages that could be investment ideas.

WAM operates several listed investment companies (LICs). Some, like WAM Leaders Ltd (ASX: WLE) and WAM Capital Limited (ASX: WAM), focus on larger companies.

There's also one called WAM Microcap Ltd (ASX: WMI), which focuses on small-cap ASX shares with a market capitalisation under $300 million at the time of acquisition.

WAM says WAM Microcap targets "the most exciting undervalued growth opportunities in the Australian microcap market".

These are the two small-cap ASX shares the fund manager outlines in its recent monthly update.

iCollege Ltd (ASX: ICT)

WAM described this business as a provider of accredited and non-accredited courses and services across Australia. It also operates an international recruitment agency. The iCollege share price is up 60% since 24 August 2022.

It was noted that the COVID-19 period has been challenging, but the reopening of Australian borders and a range of government initiatives aimed at encouraging international students to return has led to iCollege seeing a "surge" in demand from overseas students.

The fund manager also said the small-cap ASX share is strongly positioned to benefit from this trend with the company revealing in its FY22 result that the number of English language students has exceeded pre-COVID levels. New student offers and enrolments at Go Study are increasing on a month-over-month basis.

The intake of international bachelor degree students is rising steeply and will "contribute to strong revenue growth into FY24 and onwards".

Concluding its positive thoughts, WAM explained:

We believe the market is underestimating the company's operating leverage associated with filling incremental classroom capacity, underpinning earnings upgrades. The strong balance sheet also provides opportunity to deploy capital into earnings accretive acquisitions over the medium-term.

CogState Limited (ASX: CGS)

The other small-cap ASX share mentioned, CogState, was described as a leading technology company optimising brain health assessments to advance medicine development and enable earlier clinical insights in healthcare. The CogState share price is up 30% since 27 September 2022.

Last month, its global commercial partner Eisai reported a successful phase three trial result for its new Alzheimer's disease drug, which met both its primary and secondary endpoints.

WAM noted that the drug reduced clinical cognitive decline by 27% compared to a placebo in a study involving 1,795 participants with early Alzheimer's disease.

Eisai will continue to seek approval for the drug in the US, Japan, and Europe.

The fund manager said the adoption of Cogstate's technologies at scale has been predicated on a commercialised drug in the market to screen for potential patients suitable for treatment.

Assuming the drug is approved, WAM said:

We anticipate this to materialise in the 2023 calendar year, driving upgrades to revenue and earnings. Additional opportunities exist with highly-anticipated read-outs from two other pivotal phase three Alzheimer's drugs, providing near-term catalysts for the company.

Motley Fool contributor Tristan Harrison has positions in WAM MICRO FPO. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CogState Limited. The Motley Fool Australia has positions in and has recommended CogState Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Two people comparing and analysing material.
Opinions

Are BHP or Wesfarmers shares a better buy?

Should investors be more interested in the owner of Bunnings or Australia’s biggest miner?

Read more »

Woman with a moving box on her head.
Opinions

1 ASX small-cap stock that could benefit from the rental crisis

Noticed the rental market shortage? This may be an opportunity for this ASX small-cap share.

Read more »

A happy boy with his dad dabs like a hero while his father checks his phone.
Opinions

I'd use the Warren Buffett method and buy these 2 ASX shares

Warren Buffett’s advice has steered me to these stocks.

Read more »

A miner stands in front oh an excavator at a mine site
Opinions

3 reasons ASX uranium stocks can keep charging higher into 2025

I think the recent sell-down in ASX uranium stocks has been overdone. Here’s why.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Opinions

3 reasons to be positive on ASX 200 shares in FY25 (and 3 to be wary)

Vinay Ranjan from Airlie Funds Management says we should ignore market noise and buy quality stocks.

Read more »

A businessman hugs his computer and smiles.
Opinions

2 outstanding ASX 200 shares to buy and hold for a decade

I think these ASX 200 shares will continue to reward investors for years to come.

Read more »

A group of three men in hard hats and high visibility vests stand together at a mine site while one points and the others look on with piles of dirt and mining equipment in the background.
Opinions

Down 40% in under 3 years, is the Lynas share price due a bounce?

Is there any hope for Lynas shares?

Read more »

A man in a suit looks serious while discussing business dealings with a couple as they sit around a computer at a desk in a bank home lending scenario.
Share Market News

Is there any chance of an interest rate cut in Australia next week?

Here's what the experts think will happen.

Read more »